IL-6 and APPs: anti-inflammatory and immunosuppressive mediators (Q41591668)

4 October 2017

1 reference

title

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators (English)

1 reference

4 October 2017

2

Dinarello CA

1 reference

4 October 2017

Tilg H

1

1 reference

PubMed ID

9293158

4 October 2017

Mier JW

series ordinal

3

1 reference

4 October 2017

1 September 1997

1 reference

4 October 2017

1 reference

4 October 2017

18

1 reference

4 October 2017

428-432

1 reference

4 October 2017

9

1 reference

The acute-phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor–α

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Interleukin-6 in biology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

The role of interleukin-1 in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Long-term consequences of interleukin-6 overexpression in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

The role of interleukin-6 in mucosal IgA antibody responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Defective inflammatory response in interleukin 6-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Suppression of cytokine production by supernatants from CD8+ lymphocytes activated by mycobacterial fractions: the role of interleukins 4 and 6

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Ciliary neurotrophic factor combined with soluble receptor inhibits synthesis of proinflammatory cytokines and prostaglandin-E2 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Ciliary neurotrophic factor inhibits brain and peripheral tumor necrosis factor production and, when coadministered with its soluble receptor, protects mice from lipopolysaccharide toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Acute Phase Protein, Serum Amyloid A, Inhibits IL-1- and TNF-Induced Fever and Hypothalamic PGE2 in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Administration of alpha 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

C-reactive protein inhibits intracellular calcium mobilization and superoxide production by guinea pig alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Inhibition of neutrophil superoxide production by human plasma α1 -antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Antiproteinases protect cultured lung endothelial cells from endotoxin injury

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

α2-macroglobulin ‘fast’ forms inhibit superoxide production by activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901103-1

7 January 2021

10.1016/S0167-5699(97)01103-1

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9293158